The treatment of hypertension in diabetic nephropathy

Journal of Human Hypertension

Volumn 10, Issue 10, 1996, Pages 675-677

  Lewis, E J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ACE inhibition; Insulin dependent diabetes; Kidney

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY;

DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC;

EID: 0030472943     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Keane WF et al. Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Interm Med 1989; 111: 503-516.
2. Mathiesen EF, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria, Br Med J 1991; 303: 81-87.
3. Viberti G, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group. JAMA 1994; 271: 275-279.
4. Lewis EJ, Hunsiker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1989; 329: 1456-1462.